Cargando…
Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To deve...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025779/ https://www.ncbi.nlm.nih.gov/pubmed/33842325 http://dx.doi.org/10.3389/fonc.2021.620981 |
_version_ | 1783675555246243840 |
---|---|
author | Deng, Yan Ming, Bing Zhou, Ting Wu, Jia-long Chen, Yong Liu, Pei Zhang, Ju Zhang, Shi-yong Chen, Tian-wu Zhang, Xiao-Ming |
author_facet | Deng, Yan Ming, Bing Zhou, Ting Wu, Jia-long Chen, Yong Liu, Pei Zhang, Ju Zhang, Shi-yong Chen, Tian-wu Zhang, Xiao-Ming |
author_sort | Deng, Yan |
collection | PubMed |
description | BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To develop and validate radiomics models derived from multiparametric MRI to distinguish pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions. METHODS: This retrospective study included 119 patients from two independent institutions. Patients from one institution were used as the training cohort (51 patients with PDAC and 13 patients with MFCP), and patients from the other institution were used as the testing cohort (45 patients with PDAC and 10 patients with MFCP). All the patients had pathologically confirmed results, and preoperative MRI was performed. Four feature sets were extracted from T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and the artery (A) and portal (P) phases of dynamic contrast-enhanced MRI, and the corresponding radiomics models were established. Several clinical characteristics were used to discriminate PDAC and MFCP lesions, and clinical model was established. The results of radiologists’ evaluation were compared with pathology and radiomics models. Univariate analysis and the least absolute shrinkage and selection operator algorithm were performed for feature selection, and a support vector machine was used for classification. The receiver operating characteristic (ROC) curve was applied to assess the model discrimination. RESULTS: The areas under the ROC curves (AUCs) for the T1WI, T2WI, A and, P and clinical models were 0.893, 0.911, 0.958, 0.997 and 0.516 in the primary cohort, and 0.882, 0.902, 0.920, 0.962 and 0.649 in the validation cohort, respectively. All radiomics models performed better than clinical model and radiologists’ evaluation both in the training and testing cohorts by comparing the AUC of various models, all P<0.050. Good calibration was achieved. CONCLUSIONS: The radiomics models based on multiparametric MRI have the potential ability to classify PDAC and MFCP lesions. |
format | Online Article Text |
id | pubmed-8025779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80257792021-04-08 Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions Deng, Yan Ming, Bing Zhou, Ting Wu, Jia-long Chen, Yong Liu, Pei Zhang, Ju Zhang, Shi-yong Chen, Tian-wu Zhang, Xiao-Ming Front Oncol Oncology BACKGROUND: It is difficult to identify pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions through conventional CT or MR examination. As an innovative image analysis method, radiomics may possess potential clinical value in identifying PDAC and MFCP. To develop and validate radiomics models derived from multiparametric MRI to distinguish pancreatic ductal adenocarcinoma (PDAC) and mass-forming chronic pancreatitis (MFCP) lesions. METHODS: This retrospective study included 119 patients from two independent institutions. Patients from one institution were used as the training cohort (51 patients with PDAC and 13 patients with MFCP), and patients from the other institution were used as the testing cohort (45 patients with PDAC and 10 patients with MFCP). All the patients had pathologically confirmed results, and preoperative MRI was performed. Four feature sets were extracted from T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and the artery (A) and portal (P) phases of dynamic contrast-enhanced MRI, and the corresponding radiomics models were established. Several clinical characteristics were used to discriminate PDAC and MFCP lesions, and clinical model was established. The results of radiologists’ evaluation were compared with pathology and radiomics models. Univariate analysis and the least absolute shrinkage and selection operator algorithm were performed for feature selection, and a support vector machine was used for classification. The receiver operating characteristic (ROC) curve was applied to assess the model discrimination. RESULTS: The areas under the ROC curves (AUCs) for the T1WI, T2WI, A and, P and clinical models were 0.893, 0.911, 0.958, 0.997 and 0.516 in the primary cohort, and 0.882, 0.902, 0.920, 0.962 and 0.649 in the validation cohort, respectively. All radiomics models performed better than clinical model and radiologists’ evaluation both in the training and testing cohorts by comparing the AUC of various models, all P<0.050. Good calibration was achieved. CONCLUSIONS: The radiomics models based on multiparametric MRI have the potential ability to classify PDAC and MFCP lesions. Frontiers Media S.A. 2021-03-24 /pmc/articles/PMC8025779/ /pubmed/33842325 http://dx.doi.org/10.3389/fonc.2021.620981 Text en Copyright © 2021 Deng, Ming, Zhou, Wu, Chen, Liu, Zhang, Zhang, Chen and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Deng, Yan Ming, Bing Zhou, Ting Wu, Jia-long Chen, Yong Liu, Pei Zhang, Ju Zhang, Shi-yong Chen, Tian-wu Zhang, Xiao-Ming Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title | Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title_full | Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title_fullStr | Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title_full_unstemmed | Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title_short | Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions |
title_sort | radiomics model based on mr images to discriminate pancreatic ductal adenocarcinoma and mass-forming chronic pancreatitis lesions |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025779/ https://www.ncbi.nlm.nih.gov/pubmed/33842325 http://dx.doi.org/10.3389/fonc.2021.620981 |
work_keys_str_mv | AT dengyan radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT mingbing radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT zhouting radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT wujialong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT chenyong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT liupei radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT zhangju radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT zhangshiyong radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT chentianwu radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions AT zhangxiaoming radiomicsmodelbasedonmrimagestodiscriminatepancreaticductaladenocarcinomaandmassformingchronicpancreatitislesions |